The big guy starts with raising pigs

Chapter 621 Reaching an Agreement (33 asks for a monthly ticket)
In the blink of an eye, more than a month has passed
By the end of August, the third phase clinical trial of 'Loquat Anticancer Toxin' was finally successfully completed.

When the Shanshen Group announced the news, it caused a huge sensation again.

Patients across the country are very excited and excited,

Because the end of the Phase III trial means that this new anti-cancer drug will be on the market immediately.

"Shanshen Group is amazing! In just over a month, more than 1000 terminal patients have been discharged from the hospital."

"Haha, the people of Shancheng sent a congratulatory message, congratulating the complete success of the third phase clinical trial of Shanshen's new drug!"

"The people of Guizhou Province also sent a congratulatory message, wishing the successful launch of the new drug of Shanshen Group!"

Netizens across the country were very excited and sent their own congratulations online.

For high-tech enterprises like Shanshen Group,

Especially the enterprises that benefit ordinary people, everyone feels very proud and proud.

Whether it is advanced breeding technology or new anti-cancer drug technology that has just emerged,
These are world-leading high-tech technologies that are not available in Western developed countries.

Netizens all hope that Shanshen Group can make persistent efforts,
Work hard to develop, master more black technologies, and contribute more to the rise of China.

…………

The successful Phase III clinical trial of Shanshen Group's new anti-cancer drug has also caused an uproar abroad.

Netizens from many countries are talking about it.

"Huaxia's anti-cancer drug has finally been tested successfully. I wonder when it will be launched in our country?" A Scottish netizen asked on a social networking site.

Soon, an American replied enviously: "You don't need to ask. You must be able to buy it earlier than us. Our negotiations have not made any progress!"

"Haha, you also have today, who made you want to be slapped in the face, just restricted others from entering your country's market, and now begging others to enter, do you think it will be so easy?" A Pakistani netizen gloated in his reply arrive.

Net names in many countries are criticizing the domineering Americans

Everyone thinks that Americans are doing this to themselves, and they deserve to be slapped in the face by the Shanshen Group.

In the blink of an eye, the time came to September [-]st.

At nine o'clock this morning,

The conference hall of the International Convention and Exhibition Center in the provincial capital is already full of people.

Representatives from more than 100 countries and hundreds of companies gathered together to compete for the agency rights of new anti-cancer drugs.

Some countries take the route of government procurement, and the governments of these countries come to participate in person.

As for countries that do not go to the government to agree to purchase, then let other companies compete for agency rights.

Today, Zhang Hai, as a representative of Shanshen Group, also attended the meeting,

However, Liu Minghua, the person in charge of Shanshen Pharmaceutical, presided over the meeting today.

At 09:30 in the morning, the agency bidding conference officially started.

The host Liu Minghua walked to the rostrum.

"Good morning, friends at home and abroad, welcome to this bidding conference,"

In fact, this bidding conference is just going through the motions.

Because one month before the start of the conference, countries and companies approached Shanshen Group one after another,
Among them, the agency rights in more than 100 countries and regions around the world have been authorized before this.

Today there are only seventy or eighty small countries in Africa and Central America left.

Therefore, the competition in today's agency bidding field is not fierce.
In just one day, the new drug bidding conference of Shanshen Group finally ended successfully.

The next day, when Shanshen Group announced the countries and regions that have reached cooperation,

Countries around the world reacted differently.

It can be said that some families are happy and some are sad.

The countries and companies that have obtained agency rights are very happy,
And those countries that did not get it are extremely depressed, such as the United States and the kangaroo country.

At present, the agency powers of these countries are still under 'friendly' negotiation,

When the people of the United States saw this list, they were completely angry. There was no United States on it!
"My God! What the hell are those damn politicians doing? Why can't they even do such a small thing?"

"Damn it, why haven't we reached an agreement after talking for more than a month?"

"If you don't do it well, get out of here, or you'll go to hell!"

The comments of these American netizens are still moderate.

Those suffering from cancer are not easy to talk about.

After learning that the government failed to obtain the proxy, everyone's anger suddenly erupted like a volcano!

As a result, the United States once again experienced a huge chaos. Those who didn't know it thought that a civil war had broken out in the United States.

Domestic chaos into a pot of porridge,

The U.S. government finally couldn't sit still.

The old man immediately ordered the negotiators to reach an agreement with the Huaxia government no matter what, and give an explanation to the domestic people.

The representative of the United States had no choice but to agree to certain conditions proposed by Huaxia, and the two sides quickly reached an agreement.

Seeing that the boss has compromised
How can Kangaroo Country and other dog legs continue to insist, and they all made concessions in the negotiations,
Therefore, the last few countries finally reached an agreement with the Shanshen Group.

Three days later, Shanshen Group's new anti-cancer drug "Loquat Anti-Cancer" was successfully launched in the markets of these countries.

………………

After the agency right was auctioned off, Liu Minghua reminded Zhang Hai:
"Boss, what about the 500 million yuan farm in Batie?"

Zhang Hai had already planned this matter. He planned to let Miao Liwei go to Batie to take charge of the development of the farm.
When the farm over there is stable, it can be handed over to the staff over there for management.

Because Shanshen Seed Industry has a big branch over there.

The employees of the branch should have a better understanding of the market of Pakistan Railway.

"That's good, it will be no problem to have Mr. Miao join the team!" Hearing Zhang Hai's arrangement, Liu Minghua nodded with a smile.

The two chatted for a while, and Liu Minghua reported to Zhang Haihui again:
"By the way, boss, Dr. Gu has prepared a new topic, I hope you can approve it."

Zhang Hai looked at him curiously and asked, "New subject? What subject?"

"Cellular immunotherapy of tumors" Liu Minghua said seriously.

Because Gu Xingzhou is an expert in cellular immunity, his main research direction during his doctoral period was cellular immunity.

This time his team successfully discovered a new drug for the treatment of respiratory tract cancer, which gave him great confidence and inspiration.
Therefore, Gu Xingzhou is going to start this new topic, hoping to overcome the worldwide problem of cancer.

"Do you need a lot of research funding?" Zhang Hai was a little surprised, because if the research funding does not exceed 1000 million, he does not need to report to himself.

It used to be 500 million, but with the development of Shanshen Pharmaceutical, Zhang Hai also gave Liu Minghua higher funding authority.

"Well, it takes about 3000 million yuan!" Liu Minghua said with some embarrassment.

"The main reason is that the experimental equipment is more expensive." Liu Minghua quickly explained.

"I see, tell him to prepare the project application report, and I will approve it at that time." Zhang Hai nodded, thinking that such a research company should support,

What's more, Gu Xingzhou has just developed a drug called 'Loquat Anti-Cancer' for the company.

　It's finally finished. I adjusted the update time today. I'm tired of writing. I hope book friends will give me a monthly ticket to encourage and encourage!
　　
　
(End of this chapter)